SCHEMBL7466733

SCHEMBL7466733

CCCCCc1c[nH]c2ccc(Cl)cc12

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 4/20 0.69
HTR2A P28223 4/20 0.65
TRPM8 Q7Z2W7 1/20 0.65
GPR84 Q9NQS5 1/20 0.63
GFER P55789 1/20 0.61
HSD17B10 Q99714 1/20 0.61
HTR1A P08908 6/20 0.58
HTR1D P28221 4/20 0.58
HTR1B P28222 4/20 0.58
MTNR1A P48039 1/20 0.57
MTNR1B P49286 1/20 0.57
TSHR P16473 1/20 0.56
MEN1 O00255 1/20 0.55
LMNA P02545 1/20 0.55
TP53 P04637 1/20 0.55
MAPT P10636 1/20 0.55
KMT2A Q03164 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
ADRA2A P08913 1/20 0.53
DRD2 P14416 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28117188 0.95 SLC6A4 (0.71) SLC6A4HTR2ATRPM8GPR84GFER
SCHEMBL12464834 0.89 HTR2A (0.71) SLC6A4HTR2ATRPM8GPR84GFER
SCHEMBL8808469 0.86 SLC6A4 (0.67) SLC6A4HTR2ATRPM8GPR84GFER
SCHEMBL16433301 0.84 SLC6A4 (0.65) SLC6A4HTR2ATRPM8GPR84GFER
SCHEMBL15676249 0.84 HTR2A (0.69) SLC6A4HTR2ATRPM8GPR84GFER
SCHEMBL891985 0.83 SLC6A4 (0.67) SLC6A4HTR2ATRPM8GPR84GFER
SCHEMBL892282 0.83 SLC6A4 (0.67) SLC6A4HTR2ATRPM8GPR84GFER
SCHEMBL892989 0.83 HTR2A (0.82) SLC6A4HTR2ATRPM8GPR84GFER
SCHEMBL10119751 0.82 GPR84 (0.73) SLC6A4HTR2ATRPM8GPR84GFER
SCHEMBL6978810 0.81 SLC6A4 (0.69) SLC6A4HTR2AHTR1AHTR1DHTR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1058678-B1 METAL-CATALYZED ARYLATIONS AND VINYLATIONS OF HYDRAZINES, HYDRAZONES, HYDROXYLAMINES AND OXIMES MASSACHUSETTS INST TECHNOLOGY (US) 2002-12-11 EP disclosed
US-6465693-B2 TRANSITION METAL CATALYZED ARYLATION OR VINYLATION; COMBINATORIAL CHEMISTRY MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2002-10-15 US disclosed
US-20010031894-A1 Metal-catalyzed arylations of hydrazines, hydrazones, and related substrates BUCHWALD STEPHEN L (US) 2001-10-18 US disclosed
US-6235936-B1 TRANSITION METAL CATALYST FOR ARYLATION MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2001-05-22 US disclosed
EP-1058678-A2 METAL-CATALYZED ARYLATIONS AND VINYLATIONS OF HYDRAZINES, HYDRAZONES, HYDROXYLAMINES AND OXIMES Massachusetts Institute of Technology (US) 2000-12-13 EP disclosed
WO-1999043643-A2 METAL-CATALYZED ARYLATIONS AND VINYLATIONS OF HYDRAZINES, HYDRAZONES, HYDROXYLAMINES AND OXIMES MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1999-09-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010031894-A1 Metal-catalyzed arylations of hydrazines, hydrazones, and related substrates IDO1, IDO2, AHR SLC6A4 563/4885HTR2A 585/4885TRPM8 3988/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.